Guide
Innovative agreements: Exploring alternative payment models
Learn why payers are embracing contracts that support emerging and complex therapies
Healthcare payers and biopharma companies have increasingly adopted innovative agreements, such as outcomes-based contracts, disease management programs, and subscription models, which aim to improve health outcomes and/or reduce cost. As the industry drives towards value-based pricing, a growing emphasis is being placed on novel payment models, especially for cell and gene therapies.
Watch today to learn:
- What really matters to payers?
- What are the most common drivers?
- The key elements in successful partnerships
- Upcoming financial products for cell and gene therapies
Enter your information below to access the webinar on demand.
